tiprankstipranks
Monogram Orthopaedics Secures Funding and Pursues FDA Approval
Company Announcements

Monogram Orthopaedics Secures Funding and Pursues FDA Approval

Don't Miss our Black Friday Offers:

Monogram Orthopaedics Inc ( (MGRM) ) has issued an announcement.

Monogram Technologies Inc. successfully closed its Series D Preferred Stock offering on October 1, 2024, raising around $13 million with an oversubscribed public offering thanks to the participation of 3,023 investors. This capital boost is aimed at fueling the company’s near-term commercialization milestones, clinical trials, and further tech development. Simultaneously, Monogram is working towards obtaining FDA clearance for its orthopedic surgery innovations, signaling investor confidence in the company’s vision and future prospects.

Find detailed analytics on MGRM stock on TipRanks’ Stock Analysis page.

Related Articles
Austin AngeloIs MGRM a Buy, Before Earnings?
TipRanks Auto-Generated NewsdeskMonogram Orthopaedics Advances with FDA Filing and Partnerships
TipRanks Auto-Generated NewsdeskMonogram Orthopaedics Wins 2024 Orthopedic Company Award
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App